NCT04050709View on ClinicalTrials.gov

QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

July 18, 2019

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Locally Advanced Solid TumorMetastatic CancerSolid Tumor

Interventions

BIOLOGICAL

PD-L1 t-haNK

PD-L1 t-haNK Suspension for Infusion

Trial Locations (1)

90245

Chan Soon-Shiong Institute for Medicine, El Segundo

Sponsors

Lead Sponsor

ImmunityBio, Inc.

All Listed Sponsors

lead

ImmunityBio, Inc.

INDUSTRY